收稿日期: 2023-08-13
录用日期: 2023-09-22
网络出版日期: 2023-10-28
基金资助
河南省科技攻关项目(212102310764);国家自然科学基金(81970686)
Screening and functional analysis of mutations in NEUROD1 gene in pedigrees of maturity-onset diabetes of the young
Received date: 2023-08-13
Accepted date: 2023-09-22
Online published: 2023-10-28
Supported by
Project of Science and Technology of Henan Province(212102310764);National Natural Science Foundation of China(81970686)
目的·筛查青少年的成人起病型糖尿病(maturity-onset diabetes of the young,MODY)家系中NEUROD1基因突变,分析突变与中国人MODY6发病的相关性及其潜在的致病机制。方法·采用PCR-直接测序法对96例GCK/MODY2、HNF1A/MODY3、HNF1B/MODY5突变阴性的中国MODY先证者进行NEUROD1突变筛查,同时比较96例MODY先证者与100例非糖尿病对照者NEUROD1基因变异的基因型频率。采用从头建模法构建NEUROD1蛋白野生型和突变体的3D结构,采用双荧光素酶报告基因系统检测野生型和突变体蛋白对胰岛素基因转录活性的影响。结果·在一个MODY家系中发现NEUROD1基因杂合错义突变Glu59Gln(NM_002500.5,c.175G>C)。3D结构分析发现,该突变将野生型中带负电荷的Glu59转化为突变中不带电荷的Gln59,导致两个盐桥键Glu59-Arg54和Glu59-Lys88缺失,并形成一个新的氢键Gln59- Arg54。与野生型相比,Glu59Gln突变体的胰岛素基因转录活性下降36.3%(P<0.05)。与非糖尿病对照相比,96例MODY先证者中Ala45Thr(G-A)变异的AA+GA基因型频率显著升高(P=0.002)。结论·Glu59Gln突变改变了NEUROD1蛋白N端的分子构象,导致其胰岛素基因转录活性显著下降,是该家系突变携带者胰岛素分泌缺陷的原因。Ala45Thr变异与MODY6先证者糖尿病发病年龄的提前有关。
关键词: 青少年的成人起病型糖尿病; NEUROD1基因; MODY6; Glu59Gln突变; 功能解析
张娟 , 葛晓旭 , 张荣 , 蒋伏松 , 蒋燕燕 , 李鸣 , 李甜甜 , 刘婵薇 , 陈亚婷 , 刘丽梅 . 青少年的成人起病型糖尿病家系NEUROD1基因突变的筛查与功能解析[J]. 上海交通大学学报(医学版), 2023 , 43(10) : 1255 -1261 . DOI: 10.3969/j.issn.1674-8115.2023.10.005
Objective ·To screen the mutations of NEUROD1 gene in families of maturity-onset diabetes of the young (MODY), and investigate the correlation between the mutation and MODY6 and its potential pathogenesis in Chinese. Methods ·PCR-direct sequencing was used for screening NEUROD1 mutations from 96 MODY probands who were negative for mutations in the GCK/MODY2, HNF1A/MODY3 and HNF1B/MODY5 genes, and the genotypic frequency of NEUROD1 variations were compared between the 96 MODY probands and 100 non-diabetic control subjects. A de novo modeling method was used to predict the three-dimensional (3D) structures of wild type (WT) and mutated NEUROD1 proteins. Transcriptional activities of both WT and mutant of NEUROD1 on insulin gene were detected by using dual luciferase reporter gene system. Results ·Glu59Gln (NM_002500.5, c.175G>C), a heterozygous missense mutation in the NEUROD1 gene, was identified in a MODY pedigree. 3D structural analysis showed that the mutation transformed the negatively charged Glu59 of WT into uncharged mutation Gln59, leading to the loss of Glu59-Arg54 and Glu59-Lys88, two salt bridge bonds, and the formation of Gln59-Arg54, one new hydrogen bond. Transcriptional activity of Glu59Gln mutant for insulin gene was reduced by 36.3% when compared with that of WT (P<0.05). A common variation Ala45Thr (G-A) was identified, and AA+GA genotypic frequency of the variation was significantly elevated in the 96 MODY probands in comparison to non-diabetic control subjects (P=0.002). Conclusion ·Glu59Gln mutation alters the N-terminal molecular conformation of NEUROD1 protein, resulting in decreased transcriptional activity of insulin gene, which is the cause of the defective insulin secretion in mutation carriers of the MODY6 pedigree. The Ala45Thr variation is associated with earlier age of onset of diabetes in MODY6 probands.
1 | BOHUSLAVOVA R, SMOLIK O, MALFATTI J, et al. NEUROD1 is required for the early α and β endocrine differentiation in the pancreas[J]. Int J Mol Sci, 2021, 22(13): 6713. |
2 | ARAMATA S, HAN S I, YASUDA K, et al. Synergistic activation of the insulin gene promoter by the beta-cell enriched transcription factors MafA, Beta2, and Pdx1[J]. Biochim Biophys Acta, 2005, 1730(1): 41-46. |
3 | HORIKAWA Y, ENYA M. Genetic dissection and clinical features of MODY6 (NEUROD1-MODY)[J]. Curr Diab Rep, 2019, 19(3): 12. |
4 | NAYA F J, HUANG H P, QIU Y, et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice[J]. Genes Dev, 1997, 11(18): 2323-2334. |
5 | ROMER A I, SINGER R A, SUI L, et al. Murine perinatal β-cell proliferation and the differentiation of human stem cell-derived insulin-expressing cells require NEUROD1[J]. Diabetes, 2019, 68(12): 2259-2271. |
6 | BRODOSI L, BARACCO B, MANTOVANI V, et al. NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report[J]. BMC Endocr Disord, 2021, 21(1): 202. |
7 | RUBIO-CABEZAS O, MINTON J A, KANTOR I, et al. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities[J]. Diabetes, 2010, 59(9): 2326-2331. |
8 | LI Y Y, WANG H, ZHANG Y Y. Neuronal Differentiation 1 gene Ala45Thr polymorphism and type 2 diabetes mellitus: a meta-analysis of 7, 940 subjects[J]. Nutr Metab Cardiovasc Dis, 2021, 31(6): 1809-1821. |
9 | LIU L M, JIA W P, ZHENG T S, et al. Ala45Thr variation in neuroD1 gene is associated with early-onset type 2 diabetes with or without diabetic pedigree in Chinese[J]. Mol Cell Biochem, 2006, 290(1/2): 199-204. |
10 | LIU L, FURUTA H, MINAMI A, et al. A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family[J]. Mol Cell Biochem, 2007, 303(1/2): 115-120. |
11 | American Diabetes Association Professional Practice Committee. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(suppl 1): S17-S38. |
12 | YANG J Y, ZHANG Y. I-TASSER server: new development for protein structure and function predictions[J]. Nucleic Acids Res, 2015, 43(W1): W174-W181. |
13 | CHAPLA A, MRUTHYUNJAYA M D, ASHA H S, et al. Maturity onset diabetes of the young in India: a distinctive mutation pattern identified through targeted next-generation sequencing[J]. Clin Endocrinol (Oxf), 2015, 82(4): 533-542. |
14 | GONSORCíKOVá L, PR?HOVá S, CINEK O, et al. Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1[J]. Pediatr Diabetes, 2008, 9(4 pt 2): 367-372. |
15 | MALECKI M T, JHALA U S, ANTONELLIS A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus[J]. Nat Genet, 1999, 23(3): 323-328. |
16 | HORIKAWA Y, ENYA M, MABE H, et al. NEUROD1-deficient diabetes (MODY6): identification of the first cases in Japanese and the clinical features[J]. Pediatr Diabetes, 2018, 19(2): 236-242. |
17 | FAJANS S S, BELL G I. MODY: history, genetics, pathophysiology, and clinical decision making[J]. Diabetes Care, 2011, 34(8): 1878-1884. |
18 | 刘丽梅, 赵蔚菁, 郑泰山, 等. 早发2型糖尿病家系NeuroD1基因突变筛查与功能研究[J]. 中华内分泌代谢杂志, 2009, 25(1): 34-38. |
18 | LIU L M, ZHAO W J, ZHENG T S, et al. Mutation screening and functional study of NeuroD1 gene in pedigrees with early-onset type 2 diabetes mellitus [J]. Chinese Journal of Endocrinology and Metabolism, 2009, 25(1): 34-38. |
/
〈 |
|
〉 |